Alterity Therapeutics (ATHE) has released an update.
Alterity Therapeutics Limited has announced the cessation of over 1.9 billion unquoted options due to their expiry on August 31, 2024, without any exercise or conversion. Following this cessation, the company’s issued capital comprises various classes of equity securities and options, with ordinary fully paid shares totaling over 5.3 billion. This change in the company’s securities structure could impact its market capitalization and investor interests.
For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.
